Under the agreement, researchers at the institute will have access to Ingenuity Pathway Analysis 3.0 and Ingenuity Pathways Analysis Integration Module.
The company's Pathway Analysis product allows scientists to create and analyze custom networks for targets, biomarkers, disease areas, and processes.